STOCK TITAN

Amwell expands clinical programs portfolio to include Hello Heart cardiovascular health risk management solution

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Amwell (NYSE: AMWL) has announced a partnership with Hello Heart, integrating the digital preventive heart health solution into its clinical programs portfolio on the Amwell Converge™ platform. This collaboration allows Amwell health plan clients to offer their employer accounts Hello Heart's cardiovascular solution to eligible members with high blood pressure, high cholesterol, or other cardiovascular disease risk factors.

Members can access Hello Heart's solution through their existing Amwell-powered offering, alongside virtual primary care, urgent care, behavioral health, and other clinical programs. The program provides users with a connected blood pressure monitor and an app offering personalized daily coaching and metric tracking. This integration aims to address the clinical and financial burden of heart disease, which costs health plans an average of $12,500 per member per year.

Amwell (NYSE: AMWL) ha annunciato una partnership con Hello Heart, integrando la soluzione digitale preventiva per la salute del cuore nel suo portfolio di programmi clinici sulla piattaforma Amwell Converge™. Questa collaborazione consente ai clienti dei piani sanitari di Amwell di offrire ai loro conti aziendali la soluzione cardiovascolare di Hello Heart ai membri idonei con ipertensione, colesterolo alto o altri fattori di rischio per malattie cardiovascolari.

I membri possono accedere alla soluzione di Hello Heart tramite l'offerta esistente supportata da Amwell, accanto a cure primarie virtuali, cure urgenti, salute comportamentale e altri programmi clinici. Il programma fornisce agli utenti un monitor della pressione sanguigna connesso e un'app che offre coaching personalizzato quotidiano e monitoraggio delle metriche. Questa integrazione mira a affrontare il carico clinico e finanziario delle malattie cardiache, che costa ai piani sanitari una media di $12.500 per membro all'anno.

Amwell (NYSE: AMWL) ha anunciado una asociación con Hello Heart, integrando la solución digital preventiva de salud cardíaca en su portafolio de programas clínicos en la plataforma Amwell Converge™. Esta colaboración permite a los clientes de planes de salud de Amwell ofrecer a sus cuentas laborales la solución cardiovascular de Hello Heart a los miembros elegibles con hipertensión, colesterol alto u otros factores de riesgo de enfermedades cardiovasculares.

Los miembros pueden acceder a la solución de Hello Heart a través de su oferta existente impulsada por Amwell, además de atención primaria virtual, atención urgente, salud mental y otros programas clínicos. El programa proporciona a los usuarios un monitor de presión arterial conectado y una aplicación que ofrece coaching diario personalizado y seguimiento de métricas. Esta integración busca abordar la carga clínica y financiera de las enfermedades cardíacas, que cuesta a los planes de salud un promedio de $12,500 por miembro al año.

Amwell (NYSE: AMWL)은 Hello Heart와의 파트너십을 발표하며, 디지털 예방 심장 건강 솔루션을 Amwell Converge™ 플랫폼의 임상 프로그램 포트폴리오에 통합했습니다. 이번 협력을 통해 Amwell의 건강 계획 고객들은 고혈압, 고콜레스테롤 또는 기타 심혈관 질환 위험 요인을 가진 자격 있는 회원들에게 Hello Heart의 심혈관 솔루션을 제공할 수 있습니다.

회원들은 기존의 Amwell 기반 제공을 통해 Hello Heart의 솔루션에 접근할 수 있으며, 이에는 가상 1차 진료, 응급 치료, 행동 건강 및 기타 임상 프로그램이 포함됩니다. 이 프로그램은 사용자에게 연결된 혈압 모니터와 맞춤형 일일 코칭 및 지표 추적을 제공하는 앱을 제공합니다. 이 통합은 심장 질환의 임상적 및 재정적 부담을 해결하는 것을 목표로 하고 있습니다., 연간 회원당 평균 $12,500의 비용이 드는 심장 질환의 부담을 경감하고자 합니다.

Amwell (NYSE: AMWL) a annoncé un partenariat avec Hello Heart, intégrant la solution numérique préventive pour la santé cardiaque dans son portefeuille de programmes cliniques sur la plateforme Amwell Converge™. Cette collaboration permet aux clients des plans de santé d'Amwell d'offrir à leurs comptes employeurs la solution cardiovasculaire d'Hello Heart aux membres éligibles ayant une hypertension, un taux de cholestérol élevé ou d'autres facteurs de risque de maladies cardiovasculaires.

Les membres peuvent accéder à la solution d'Hello Heart via leur offre existante soutenue par Amwell, en plus des soins de santé primaires virtuels, des soins d'urgence, de la santé comportementale et d'autres programmes cliniques. Le programme fournit aux utilisateurs un moniteur de pression artérielle connecté et une application offrant un coaching quotidien personnalisé et un suivi des métriques. Cette intégration vise à réduire le fardeau clinique et financier des maladies cardiaques, qui coûtent en moyenne 12 500 $ par membre et par an aux plans de santé.

Amwell (NYSE: AMWL) hat eine Partnerschaft mit Hello Heart angekündigt und integriert die digitale präventive Herzgesundheitslösung in sein Portfolio klinischer Programme auf der Amwell Converge™-Plattform. Diese Zusammenarbeit ermöglicht es den Amwell-Gesundheitsplan-Kunden, ihren Arbeitgeberkonten die kardiovaskuläre Lösung von Hello Heart anzubieten für berechtigte Mitglieder mit Bluthochdruck, hohem Cholesterin oder anderen Risikofaktoren für Herzkrankheiten.

Mitglieder können über ihr bestehendes, von Amwell unterstütztes Angebot auf die Lösung von Hello Heart zugreifen, das virtuelle Primärversorgung, Notfallversorgung, Verhaltenstherapie und andere klinische Programme umfasst. Das Programm bietet den Nutzern ein verbundenes Blutdruckmessgerät und eine App, die personalisiertes tägliches Coaching und Metrik-Tracking bietet. Diese Integration soll die klinischen und finanziellen Belastungen von Herzkrankheiten ansprechen, die die Gesundheitspläne im Durchschnitt $12,500 pro Mitglied und Jahr kosten.

Positive
  • Integration of Hello Heart's cardiovascular solution into Amwell's clinical programs portfolio
  • Potential for improved heart health management and cost reduction for health plans and employers
  • Expansion of Amwell's service offerings, potentially attracting more clients and users
Negative
  • None.

Insights

The partnership between Amwell and Hello Heart represents a significant development in digital cardiovascular health management. This collaboration addresses a critical healthcare issue, as heart disease is the leading cause of death in the U.S. and a major financial burden, costing health plans an average of $12,500 per member annually.

Key points of impact:

  • Expansion of Amwell's clinical programs portfolio to include Hello Heart's solution
  • Integration of Hello Heart's program into Amwell's Converge platform, offering a seamless user experience
  • Potential for improved health outcomes and cost reduction for health plans and employers
  • Addressing a widespread health issue affecting nearly 50% of U.S. adults with high blood pressure

This partnership could lead to increased adoption of digital health solutions for cardiovascular care, potentially improving Amwell's market position and revenue streams. However, the actual financial impact will depend on the uptake by health plans and the program's effectiveness in reducing healthcare costs.

From a financial perspective, this partnership has several potential implications for Amwell:

  • Revenue Growth: By expanding its clinical programs portfolio, Amwell can potentially increase its revenue through licensing fees or revenue-sharing agreements with Hello Heart.
  • Market Expansion: The partnership may help Amwell attract more health plan clients and retain existing ones by offering a more comprehensive solution.
  • Competitive Advantage: Integrating Hello Heart's solution into the Amwell Converge platform enhances Amwell's value proposition in the digital health market.
  • Cost Efficiency: If successful, the program could lead to reduced healthcare costs for Amwell's clients, potentially strengthening client relationships and retention.

However, it's important to note that Amwell's current market cap of $143,238,804 suggests the company is still in a growth phase. The success of this partnership and its impact on Amwell's financials will likely take time to materialize and should be monitored closely in future earnings reports.

Hello Heart selects Amwell platform to extend its reach across patient populations

BOSTON and MENLO PARK, Calif., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in digital care, today announced Hello Heart, the digital leader in preventive heart health, is a partner in the Amwell clinical programs portfolio available on the Amwell Converge™ platform.

Amwell health plan clients can now offer their employer accounts the Hello Heart cardiovascular solution to eligible members and employees with high blood pressure, high cholesterol, or other risk factors for cardiovascular disease. Members can easily access the Hello Heart solution from their current Amwell-powered offering. In addition, members will have access to virtual primary care, urgent care, behavioral health and other clinical program offerings.

Heart disease is the number one cause of death in the U.S. and among the most expensive health conditions to treat, costing health plans an average of $12,500 per member per year. High blood pressure is a known risk factor for heart disease affecting almost half of U.S. adults.

Members who sign up for the digital heart health program will receive a connected blood pressure monitor and access to an app that provides personalized daily coaching and tracks key metrics to help them better manage their heart health. Also, clinicians can receive a member's results and make data-driven recommendations about their care.

“The widespread clinical and financial burden of heart disease is skyrocketing. Health plans and employers need a solution to address this crisis at scale,” said Edo Paz, M.D., senior vice president, Medical Affairs at Hello Heart. “As the market leader for preventive heart health management, Hello Heart can help organizations drive better outcomes and lower costs for large populations at risk of cardiovascular disease. We look forward to supporting the heart health of many more people as part of Amwell’s hybrid care delivery platform.”

Amwell’s clinical programs portfolio is integrated into the Amwell Converge platform and features virtual and digital care products from innovative partners addressing various health conditions. The unified ecosystem provides health plans with the technology to offer employers and their members a seamless entry point to access many solutions, creating a personalized, cost-effective, whole-person care model focused on improved clinical outcomes and driving efficiencies. Click here to learn more about the Hello Heart program available in the Amwell clinical portfolio for health plan clients.

“Our comprehensive solution is dependable, safe and secure, with a proven track record of integrating and scaling effectively. It powers a large part of the U.S. healthcare ecosystem and facilitates the exchange of data and services across our client base to make care even more efficient and accessible,” said Ido Schoenberg, M.D., CEO of Amwell. “We are delighted to include Hello Heart as our latest portfolio partner, as the company seeks to provide healthcare organizations with digital and automated support that can prevent or reverse the health and financial burdens caused by heart disease.”

Hello Heart and Amwell are sponsoring the HLTH conference Oct. 20-23 in Las Vegas. Hello Heart will demonstrate its digital cardiovascular health program in booth #2133. Amwell leaders will be in booth #5036, highlighting how Hello Heart integrates into the company’s broader clinical care portfolio.

About Hello Heart‍
Hello Heart is on a mission to change the way people care for their hearts. The company provides the first app and connected heart monitor to help people track and manage their heart health and get real-time tips. With Hello Heart, people can take steps to control their risk of heart attacks and strokes – the leading cause of death in the United States. Peer-reviewed studies show that high-risk users of Hello Heart have seen meaningful drops in blood pressure, cholesterol and even weight. Recognized as the digital leader in preventive heart health, Hello Heart is trusted by more than 120 leading Fortune 500 and government employers, national health plans, and labor organizations such as 3M, Lenovo, Northwestern Mutual, the City of Fort Worth, and the Cleveland Bakers and Teamsters Pension Fund. Hello Heart clients can save $1,676 per enrolled user annually according to a third-party analysis by the Validation Institute.

Founded in 2013, Hello Heart has raised more than $138 million from top venture firms like Khosla Ventures, IVP, and Stripes, and has been featured in The Washington Post, CNBC, CBS Evening News, and NPR. Hello Heart is a best-in-class solution on the American Heart Association’s Innovators’ Network, CVS Health Point Solutions Management offering, and many other health solution platforms. Visit www.helloheart.com for more information.

About Amwell
Amwell provides a leading hybrid care enablement platform in the United States and globally, connecting and enabling providers, payers, patients, and innovators to deliver greater access to more affordable, higher quality care. Amwell believes that hybrid care delivery will transform healthcare. The company offers a single comprehensive platform to support all digital health needs, from urgent to acute and post-acute care, chronic care management and healthy living. With nearly two decades of experience, Amwell powers the digital care of more than 50 health plans, which collectively represent more than 100 million covered lives and many of the nation’s largest health systems. For more information, please visit https://business.amwell.com/.   

©2024 American Well Corporation. All rights reserved. Amwell®, SilverCloud®, Amwell Converge™, Carepoint™ and the Amwell logo are registered trademarks of American Well Corporation.


FAQ

What is the new partnership between Amwell (AMWL) and Hello Heart?

Amwell (AMWL) has partnered with Hello Heart to include their cardiovascular health risk management solution in Amwell's clinical programs portfolio available on the Amwell Converge™ platform.

How can Amwell (AMWL) clients access the Hello Heart program?

Amwell (AMWL) health plan clients can now offer the Hello Heart cardiovascular solution to their employer accounts for eligible members with high blood pressure, high cholesterol, or other cardiovascular disease risk factors.

What does the Hello Heart program offer to Amwell (AMWL) users?

The Hello Heart program offers Amwell (AMWL) users a connected blood pressure monitor and access to an app providing personalized daily coaching and tracking of key metrics to help manage heart health.

How does this partnership aim to address heart disease costs for Amwell (AMWL) clients?

The partnership aims to help Amwell (AMWL) clients address the high costs associated with heart disease, which averages $12,500 per member per year for health plans, by providing preventive and management tools.

American Well Corporation

NYSE:AMWL

AMWL Rankings

AMWL Latest News

AMWL Stock Data

125.01M
12.29M
6.35%
49.14%
2.49%
Health Information Services
Services-business Services, Nec
Link
United States of America
Boston